Literature DB >> 20111968

Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma.

Kei-ichi Yamanaka1, Robert C Fuhlbrigge, Hitoshi Mizutani, Thomas S Kupper.   

Abstract

In advanced stages, cutaneous T cell lymphomas (CTCL) are associated with increased mortality from infections and also increased susceptibility to skin malignancies. In this study, we analyzed the complexity of the peripheral blood T cell repertoire with a sensitive b-variable (BV) complementarity-determining region 3 (CDR3) spectratyping analysis and flow cytometry in three-stage IV CTCL/Sezary syndrome patients who achieved complete clinical remission after therapy. The T cell repertoire of peripheral blood T cells before treatment was profoundly abnormal across multiple BV subfamilies. Following treatment, CDR3 spectratype patterns showed dramatic restoration of normal diversity and complexity. However, absolute CD4 counts across multiple BV families remained low for many months, even after identifiable circulating malignant T cell populations were eliminated. These data suggest that the diversity of the T cell repertoire can be recovered after successful treatment of even advanced CTCL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20111968      PMCID: PMC2892560          DOI: 10.1007/s00403-009-1023-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  30 in total

1.  Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis.

Authors:  H Mukai; T Noguchi; K Kamimura; K Nishioka; S Nishiyama
Journal:  J Dermatol       Date:  1990-08       Impact factor: 4.005

2.  Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.

Authors:  J A Pielop; I Brownell; M Duvic
Journal:  Int J Dermatol       Date:  2003-02       Impact factor: 2.736

3.  Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.

Authors:  Ezequiel Ruiz-Mateos; Rafael de la Rosa; Jaime M Franco; Manuel Martinez-Moya; Amalia Rubio; Natalia Soriano; Armando Sanchez-Quijano; Eduardo Lissen; Manuel Leal
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

4.  Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.

Authors:  B R Vowels; M Cassin; E C Vonderheid; A H Rook
Journal:  J Invest Dermatol       Date:  1992-07       Impact factor: 8.551

5.  Excision margins in high-risk malignant melanoma.

Authors:  J Meirion Thomas; Julia Newton-Bishop; Roger A'Hern; Gill Coombes; Michael Timmons; Judy Evans; Martin Cook; Jeffery Theaker; Mary Fallowfield; Trevor O'Neill; Wlodek Ruka; Judith M Bliss
Journal:  N Engl J Med       Date:  2004-02-19       Impact factor: 91.245

6.  Cutaneous malignant melanoma in association with mycosis fungoides.

Authors:  Alun V Evans; Julia J Scarisbrick; F J Child; Katharine M Acland; Sean J Whittaker; Robin Russell-Jones
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

7.  Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma.

Authors:  Nikhil Yawalkar; Katalin Ferenczi; David A Jones; Keiichi Yamanaka; Ki-Young Suh; Sarah Sadat; Thomas S Kupper
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

8.  An unusual and fatal case of disseminated cutaneous herpes simplex. Infection in a patient with cutaneous T cell lymphoma (mycosis fungoides).

Authors:  M H Goldgeier; S R Cohen; I M Braverman; K S Stenn
Journal:  J Am Acad Dermatol       Date:  1981-02       Impact factor: 11.527

9.  Infections complicating mycosis fungoides and Sézary syndrome.

Authors:  P I Axelrod; B Lorber; E C Vonderheid
Journal:  JAMA       Date:  1992-03-11       Impact factor: 56.272

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  5 in total

1.  Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Filiberto Cedeno-Laurent; Rei Watanabe; Jessica E Teague; Thomas S Kupper; Rachael A Clark; Charles J Dimitroff
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

2.  Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

Authors:  Sarfraz A Memon; Claude Sportès; Francis A Flomerfelt; Ronald E Gress; Frances T Hakim
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

Review 3.  The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication.

Authors:  Joseph S Durgin; David M Weiner; Maria Wysocka; Alain H Rook
Journal:  J Am Acad Dermatol       Date:  2020-12-22       Impact factor: 11.527

Review 4.  Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders.

Authors:  Tycel Phillips; Sumana Devata; Ryan A Wilcox
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

5.  Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity.

Authors:  Kenshiro Tsuda; Keiichi Yamanaka; Makoto Kondo; Kimiko Matsubara; Ryogen Sasaki; Hidekazu Tomimoto; Esteban C Gabazza; Hitoshi Mizutani
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.